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of the Society, ranging from promotion, study, and
research of vascular diseases to defining more clearly the
role of surgery in vascular disease.2 Other purposes
included the teaching of vascular diseases to students and
house officers, encouraging development and special
training for young surgeons interested in the field, and,
finally, having annual meetings. The SVS has been a
dynamic organization that has adapted over the years to
meet the changing needs of our specialty. Initial presenta-
tions of the Society dealt with thrombophlebitis, preven-
tion of pulmonary embolism, hypertension, treatment of
congenital pulmonic stenosis, coarctation of the aorta,
treatment of essential hypertension, and causalgia.
Revascularization of the heart was first presented in
1948, and the initial paper on temporary artificial mainte-
nance of circulation, the forerunner of the current heart-
lung machine, was presented in 1949.3 Dr Robert R.
Linton’s address in 1948, entitled “Arteriosclerotic
Popliteal Aneurysms,” was the first presentation in which
the surgical treatment of arterial disease was discussed.
Basic research was first included in 1951, when a study
entitled “Growth of Preserved Aorta Homografts—an
Experimental Study,” by Dr Julian Johnson and his col-
leagues, and a paper entitled “The Experimental Study of
Respiration Maintained by Homologous Lungs,” by Wills
Potts and his group, were presented. From this humble
beginning, the SVS evolved through the years as a forum
for presentations of cutting edge vascular research, which
currently has evolved into the advanced techniques of cell
biology, subcellular biochemistry, and gene manipulation.
In 1950, the emphasis of the program focused increasingly
on arterial occlusive disease of the intra-abdominal vessels,
as well as femoral artery occlusive disease.
In 1966, the SVS and the North American Chapter of
the International Society for Cardiovascular Surgery
(ISCVS) developed closer ties, with the two program
committees meeting simultaneously. The Joint Council
was formed to provide a governing body for both the
North American Chapter and the SVS in 1975, and the
following year, in Albuquerque, the societies had grown to
the magnitude that a professional management group
called PRRI was engaged to administer the scientific meet-
ing and organizational business, a relationship that has
been beneficial to our development and financial stability. 
For the times they are a-changin’
Bob Dylan (1963)
The 54th Annual Meeting of the Society for
Vascular Surgery (SVS) is the first of the new millen-
nium. Moving through the year 2000, we have had
numerous opportunities to reflect on the amazing
changes that our civilization has encountered in just the
past century. We must recognize that the specialty of
vascular surgery has existed for only a fraction of those
100 years. I, like many others in this room, have had the
good fortune to participate in virtually all of the signif-
icant advances in this specialty since beginning my fel-
lowship with Dr Thompson in 1974.
More recently, as an officer of the SVS for the past 6
years, I have been intimately involved with the profes-
sional activities of our specialty. From this privileged per-
spective, I have gained an understanding of our Society’s
proud past and have formulated some ideas about its
future directions. As we enter the 21st century, a brief his-
torical review of the milestones of this organization will
allow us to place the future in better perspective.
The concept of forming a society devoted to vascular
surgery was developed by Dr J. Ross Veal, who organized
a meeting on December 5, 1945, at the Southern Surgical
Association, in Hot Springs, Va.1 Attending this meeting
to discuss this possibility were Drs Arthur Allen, Isaac A.
Bigger, Arthur H. Blakemore, Barney Brooks, I. Mims
Gage, and George D. Lilly. In San Francisco on July 3,
1946, the SVS was formed. There were 31 charter mem-
bers, of whom only Drs Michael E. DeBakey and Harris B.
Schumaker survive today. Dr Alton Ochsner was elected
the first president, and the first scientific meeting of the
SVS was held the following year in Atlantic City.
Article II of the bylaws initially listed seven purposes
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In 1981, presentations on cardiac topics ceased to
appear in the program because peripheral vascular surgery
evolved separately from cardiac surgery.
The SVS, in conjunction with the ISCVS, formed the
Journal of Vascular Surgery in 1983. This premier peer-
reviewed scientific journal proved to be a milestone in
establishing vascular surgery as a clearly defined specialty.4
As an adjunct, revenue from the publication provided the
fiscal underpinning for many of the subsequent initiatives
of the two societies.
In the late 1980s, the Research Forum for basic inves-
tigative work was organized and incorporated as part of the
scientific program, and the E. J. Wylie Traveling Fellowship
was inaugurated. The Critical Issues Forum was initiated in
1988 and renamed the E. Stanley Crawford Critical Issues
Forum in 1993. In 1984, the SVS Council began discussing
the development of the Lifeline Foundation, an educational
and research foundation. An initial contribution of $50,000
from the Society reserves was made to found this organiza-
tion.5 The Lifeline Foundation supports research in vascu-
lar disease by enhancing the development of young surgical
scientists and the advancement of vascular science through
its comprehensive research funding. The foundation’s mis-
sion provides a commitment to ensure that new knowledge
concerning causes, treatment, and prevention of vascular
disease is disseminated to the medical profession and the
public. Calvin B. Ernst designed its logo. In 1992, the
Lifeline Foundation started awarding the Resident Research
Award, and more recently, in conjunction with the National
Institutes of Health, has been able to fund investigators.
As we look to chart our future course and define our
mission, we need to have a clear understanding of why the
SVS exists. This is a select society that recognizes academic
excellence in vascular surgery. The privilege of member-
ship is granted to vascular surgeons who have distin-
guished themselves with applied clinical or basic science
research. Membership is a valued accomplishment and a
reward of exceptional scholarship.
With the honor of membership comes a responsibility
to lead and to teach. For beyond the recognition of mem-
bership in a prestigious organization, the foremost mission
of the SVS must be to maintain a link to those for whom
we care—our patients. Vascular surgery needs to embrace a
commitment to issues of patient education. It is important
for our patients to realize the value of high-quality vascular
surgery provided by our members, because ultimately, it is
the citizens of our countries who will determine the viabil-
ity of our specialty. This is going to be one of the more dif-
ficult tasks for our Society. We have done an excellent job
of establishing the value of our work to our colleagues in
surgery. These efforts need to be continued on a much
grander scale. The development of the Society’s Web site is
an important beginning, but in this technologically
advanced information age, we need to expand these efforts.
The world must be able to appreciate our contributions
and recognize the importance of vascular surgery in the
health care of our countries. Other surgical organizations
have invested significant resources in developing elaborate
electronic media programs. It is important for our Society
to maintain a proactive stance that effectively educates the
public regarding the value of vascular surgery.
We also need to establish relationships with our col-
leagues internationally. We have become global citizens, and
the worldwide instantaneous electronic transfer of informa-
tion essentially eliminates geographical professional bound-
aries. At the European Society for Vascular Surgery (ESVS)
meeting in Copenhagen, I participated in their program
directors of vascular surgery meeting and can report to you
that the problems facing European vascular surgeons in
terms of practice and training were similar to our own.
Maintaining a global dialogue will expose the SVS to the
innovative solutions of our international colleagues, with
mutual benefit. Discussions have begun to develop closer
collaboration with the leaders of the ESVS, with the con-
sideration of joint meetings. These efforts will be continued
by President-Elect Ramon Berguer this next year.
At this point let me move on to what I believe are four
basic problems confronting the specialty of vascular
surgery and therefore becoming the charge of this Society.
For these challenges we have a responsibility to provide
leadership into the next millennium.
First is the need for the ongoing development of basic
research. The advances cataloged in the rich history of this
specialty would not have occurred without dedication and
financial commitment to answering basic questions about
the diseases we treat.
Second is the need to adapt to the rapidly changing field
of endovascular surgery. There has been a virtual revolution
in the treatment of abdominal aortic aneurysms, with a
variety of endovascular devices (two have been currently
approved) working their way through various levels of the
Food and Drug Administration’s regulatory process.
Percutaneous angioplasty and stenting have become the
standard of care in iliac occlusive disease. Currently,
endovascular techniques are being investigated for the
treatment of carotid artery disease.
Third is the need to deal with fiscal issues. The declines
in reimbursement to vascular surgeons by the Health Care
Financing Administration, coupled with a ratcheting
down of expenditures by health maintenance organiza-
tions and other insurance carriers, must remain a major
concern for our specialty.
Fourth is the need to recognize the continuing evolution of
vascular surgery as a distinct specialty. We have evolved from
a time when those with only basic surgical training per-
formed vascular surgery, to one where an increasingly
greater percentage of vascular surgery is performed by those
with specialized vascular training. With potential changes in
the structure of surgical training programs, altered reim-
bursement profiles, and evolution of more complex
endovascular techniques, a greater proportion of vascular
surgery will, and should, be done by vascular surgeons.
RESEARCH
Funding still remains very problematic, and with the
increasing emphasis on practice incomes by deans and
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department chairs, medical schools are less inclined to
place emphasis on basic investigation. It is critical that our
young faculty members have time and resources to allow
them to develop their careers as scientists. Our Society
needs to play an active role in the support of basic science
laboratory investigation. The formation of the Lifeline
Foundation was a beginning. The annual Research
Initiatives Conference with very successful collaboration
with investigators at the National Heart, Lung, and Blood
Institute needs continued support. We need to be diligent
mentors for young academic vascular surgeons. The pro-
gram on Wednesday dealing with scientific communica-
tion and grantsmanship is another facet of developing
research talent that deserves our commitment.
ENDOVASCULAR SURGERY
The SVS needs to encourage the continued develop-
ment of endovascular surgery and ensure that vascular sur-
geons play a significant role in its practice. We have
demonstrated that vascular surgeons can master these
techniques. The development of a session of this meeting
dedicated solely to endovascular surgery indicates the
strides that our members have made in this now rapidly
emerging field. It is important for vascular surgeons to
maintain their hegemony in the treatment of all aspects of
vascular occlusive disease. In the operating room, portable
digital fluoroscopy units with road mapping capability may
well become the pocket Doppler transducer of the next
generation of vascular surgeons. Sophisticated radiologic
techniques and the associated hardware must be part of
the armamentarium of the modern-day vascular surgeon.
There are a variety of strategies to achieve these goals;
they will depend on local customs and experience. One par-
adigm is the traditional combination of interventional radi-
ologists working in concert with vascular surgeons. This
relationship obviously will require compromise on occasion.
As in most business situations, the difficulty comes in nego-
tiating the fiscal relationships. A second strategy for an
endovascular program involves the vascular surgeon per-
forming and controlling all aspects of diagnosis and treat-
ment of vascular disease. Certainly, this model is the most
efficient way of ensuring that vascular surgeons are skillful
with catheter technology. Within some medical centers, this
may result in a rather contentious environment and may not
be applicable for all. Another relationship may find vascular
surgeons working with cardiologists. Interventional cardiol-
ogists are relatively new participants, in terms of those who
perform peripheral vascular interventions. They often have
good catheter skills and are frequently willing to collaborate
with vascular surgeons in a vascular disease unit, which could
be mutually beneficial.
We need to work with the program directors in vascu-
lar surgery and the American Board of Surgery’s Sub-board
of Vascular Surgery to ensure that our vascular surgery fel-
lows have been fully exposed to all modalities of vascular
intervention before they complete their training. To be
competitive in the marketplace, vascular surgeons must be
involved in the evolution in endovascular techniques.
The use of stented grafts for the treatment of
aneurysm disease clearly demonstrates the need for sophis-
ticated experience in the management of patients treated
with this new technology. The high incidence of technical
complications with these grafts on long-term follow-up
demonstrates the need for savvy clinical judgment and for
ongoing development of interventional techniques with
more advanced technology. Research into the effect of
endoluminal devices on the progression of abdominal aor-
tic aneurysm disease and the ultimate morbidity and mor-
tality of endoluminal repair needs continuous, rigorous
surveillance and analysis. Although recent efforts have
focused on product development, in the future we must
better understand the interactions between the aortic wall
and the endoluminal device. We must establish a basic sci-
ence foundation on which further advances in product
development can be built.
REIMBURSEMENT AND GOVERNMENT
RELATIONS
The SVS must continue to support the ongoing work
of the Government Relations Committee of the Joint
Council. Initial work in this area in dealing with the
Health Care Financing Administration was undertaken by
Norm Hertzer, who was followed by Hugh Trout.
Currently, Bob Zwolak leads this effort for our profes-
sion. Despite the intense work of the Government
Relations Committee, success has been limited to restor-
ing a few percentage points to the Medicare fee schedule.
These gains have not been enough to counteract the large
cuts that were originally instituted without our participa-
tion in the resource-based relative value scale process.
The recent success of Bob Zwolak and Gary Seabrook in
obtaining work values for 14 new Current Procedural
Terminology codes for endovascular repair of abdominal
aortic aneurysms is a significant accomplishment. With
component coding methodology, placement of a typical
aortic endograft will be assigned a number of relative
value units, which is slightly above the work value for
conventional, open aneurysm repair. With luck, this will
serve as a benchmark to increase other vascular surgery
codes in the future. Because of the work of this
Committee, at least in the short term, the fiscal integrity
of vascular surgery has been tenuously preserved.
However, we must accept that there will be an ongoing
battle to be waged over the next decade.
The next issue that is going to affect medicine has to
do with the concept of establishing ongoing credential-
ing.6 The SVS has been a leader in this for the last decade
and a half. Dr William J. Fry appointed an outcomes com-
mittee when he was president that began our involvement
in this area. Dr Norman Hertzer stressed the importance
of outcomes in his presidential address. Vascular surgery
has led the way in the studying of outcomes. Carotid
endarterectomy is probably the best studied clinical entity
in the history of medicine, in terms of disease progression
and the effect of surgical intervention on the occurrence
and survival of stroke. As certifying boards develop stan-
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dards for concurrent credentialing of surgical specialists,
vascular surgery is in a superb position to lead the way,
because much of the outcome data on which the surgical
competence is based has already been collected. These
data will undoubtedly demonstrate that fully trained vas-
cular surgeons have better mortality and morbidity pro-
files and that quality care, in the long term, costs less.
VASCULAR SURGERY AS A DISTINCT
SPECIALTY
The most important challenge we face is the continu-
ing evolution of vascular surgery as a distinct specialty. The
development of the Journal of Vascular Surgery into the
premier vascular journal in the world has established our
scientific and academic credentials. The Association of
Program Directors of Vascular Surgery has defined the
body of knowledge encompassed by the specialty of vas-
cualr surgery with the development of curriculum for vas-
cular laboratory, clinical, and basic science. The creation of
a Sub-board of Vascular Surgery in the American Board of
Surgery has led to all aspects of the examination and cer-
tification of vascular surgeons being conducted by vascu-
lar surgeons. The formation of the Advisory Committee
on Vascular Surgery by the American College of Surgeons
is the acknowledgment by the largest surgical organization
in North America that we are a separate and clearly
defined specialty.
It is important to view these changes as an evolu-
tion. The current status will continue to evolve as the
needs of our vascular surgery trainees change. I have
proposed to the Sub-board of Vascular Surgery that the
Residency Review Committee (RRC) for Surgery be
petitioned to develop a Sub-RRC for Vascular Surgery.
This will better meet the needs of our vascular fellow-
ship programs. The RRC for Radiology has successfully
created such an entity by developing a separate RRC for
both Diagnostic Radiology and Radiation Therapy. We
have evolved from a time when vascular surgery was a
mere component of a general surgeon’s repertoire, to a
time when increasingly, a greater proportion of vascular
surgery is performed by those with specialized training.
We need to maintain our standard of quality and con-
tinue to strive for technical excellence.
These are exciting and challenging times. When con-
fronted with conflict or competition, an organization must
anticipate change, react rapidly, respond intelligently, and
embrace the newest ideas. It is certain that the SVS needs
to be proactive as it continues its leadership role into this
new and challenging era. As we have done many times in
our first 54 years, we need to continue to adapt to the
changing needs of our specialty. Aware of its proud past,
the SVS needs to continue to meet the rapidly changing
needs of the future.
These times as never before are times of change. Every
aspect of our professional life is under siege. The opportu-
nity to seize the initiative and to create a vascular disease
treatment model for the coming years is upon us. Change
is not limited to our professional lives, but involves the
whole of society. It is estimated that the population will
double in the next 30 years and that the ethnic mix of that
population will change as well. The rate of new develop-
ments is greater than has ever been encountered in the his-
tory of civilization. Just look at computer technology as an
example. New developments remain “cutting edge” for
months, not years. With this explosion of technology
come quantum leaps in the fund of information available
to the populace. What is awesome today, with the
advances in the Internet, is that a poor farmer in a Third
World country has an opportunity to have access to almost
the same information as a graduate student at one of our
most prestigious universities.
Change observes no loyalties and rewards only those
who are nimble and can most quickly react to the new pri-
orities. We cannot let old ideas that have become obsolete
consume our time and energy. We must go forward in our
thinking and have a “can do” attitude. We must be able to
think “outside the box” and recognize that some of the
issues that were dominant in running our organizations
are no longer relevant, no matter the investment of time,
energy, and even emotional zeal. We must realize when it
is time to move ahead and not be hamstrung by old ideals,
old wars, and old disagreements.
My favorite car as a high school and college student
was a ’55 Chevy with three deuces as carburetors and a
Hurst floor shift and glass packs. This car got 6 mpg and
polluted the environment. As wonderful as they may seem
in retrospect to some, the 1950s are over. As far as vascu-
lar surgery is concerned, the ’80s and ’90s are over. We
will surely cherish those times as we reminisce in years to
come, but they are over. We need to adapt and move for-
ward. For those of us that are older, this is difficult,
because we tend to be set in our ways. In reality, our only
option is to get with the program.
The SVS needs to look to our younger members for
counsel and advice. They have grown up in this informa-
tion age and probably can adapt better, at least I hope so.
My chief criticism of all surgical organizations in which I
participate is that they are often dominated by the elders,
the group that is the least able to react to the issues for
change and who are reactionary in thought and ideas. We
must not continue to fight past wars instead of dealing
with future changes. We must be broad-minded enough
to listen to the ideas of others, we must have the intellec-
tual courage and confidence to come to consensus, and we
must realize that in the give and take of an organization,
no one gets everything he supports. We have to critically
look at the agenda of our Society and have the courage to
discard tenets that are no longer meaningful. Most diffi-
cult of all, we the leaders need to know how, with grace,
to pass on the torch to the next generation and complete
the transition from leader to wise senior adviser.
In conclusion, let me return to the ballad of Bob
Dylan who was perhaps more prophetic than we might
have ever imagined when he wrote these words in 1963:
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Come gather ‘round people 
Wherever you roam
And admit that the waters 
Around you have grown
And accept it that soon
You’ll be drenched to the bone,
If your time to you is worth savin’
Then you better start swimmin’ 
Or you’ll sink like a stone,
For the times they are a-changin’.
The line it is drawn
The curse it is cast 
The slow one now will
Later be fast.
As the present now
Will later be past
The order is rapidly fadin’
And the first one now
Will later be last
For the times they are a-changin’.*
It has been a privilege to serve as your president. We
must permit these changing times to lead us toward a
bright future. Thank you.
Thanks to Gary R. Seabrook, MD, and Hugh H.
Trout III, MD, for editorial assistance and Roberta Sutton
for manuscript preparation.
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